1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
4
Active Trials
200 recruiting
3
Rare Diseases
across 5 areas
0
News (30d)
Quiet
Aura Biosciences, Inc. is a company with 1 orphan drug designation across 3 rare diseases. Active clinical trials in 4 indications.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| cancer | - | Des.TrialAppr. |
| ocular melanoma | - | Des.TrialAppr. |
| uveal melanoma | modified human papillomavirus capsid protein conjugated to a near infrared dye | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
11
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
11
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio